DK141172B - Fremgangsmåde til fremstilling af virusproteiner af influenzavirus. - Google Patents

Fremgangsmåde til fremstilling af virusproteiner af influenzavirus. Download PDF

Info

Publication number
DK141172B
DK141172B DK85775AA DK85775A DK141172B DK 141172 B DK141172 B DK 141172B DK 85775A A DK85775A A DK 85775AA DK 85775 A DK85775 A DK 85775A DK 141172 B DK141172 B DK 141172B
Authority
DK
Denmark
Prior art keywords
neuraminidase
hemagglutinin
virus
influenza virus
suspension
Prior art date
Application number
DK85775AA
Other languages
Danish (da)
English (en)
Other versions
DK141172C (de
DK85775A (de
Inventor
Robert Fontanges
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of DK85775A publication Critical patent/DK85775A/da
Publication of DK141172B publication Critical patent/DK141172B/da
Application granted granted Critical
Publication of DK141172C publication Critical patent/DK141172C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK85775AA 1974-03-05 1975-03-04 Fremgangsmåde til fremstilling af virusproteiner af influenzavirus. DK141172B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7407352 1974-03-05
FR7407352A FR2262962B1 (de) 1974-03-05 1974-03-05

Publications (3)

Publication Number Publication Date
DK85775A DK85775A (de) 1975-11-03
DK141172B true DK141172B (da) 1980-01-28
DK141172C DK141172C (de) 1980-07-14

Family

ID=9135822

Family Applications (1)

Application Number Title Priority Date Filing Date
DK85775AA DK141172B (da) 1974-03-05 1975-03-04 Fremgangsmåde til fremstilling af virusproteiner af influenzavirus.

Country Status (12)

Country Link
US (1) US4136168A (de)
JP (1) JPS50160487A (de)
BE (1) BE826275A (de)
CA (1) CA1052306A (de)
CH (1) CH595106A5 (de)
DE (1) DE2508396A1 (de)
DK (1) DK141172B (de)
ES (1) ES435323A1 (de)
FR (1) FR2262962B1 (de)
GB (1) GB1469901A (de)
NL (1) NL7502623A (de)
ZA (1) ZA751357B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR68088B (de) * 1978-02-16 1981-10-30 Science Union & Cie
CA1122527A (en) * 1979-05-15 1982-04-27 Karen K. Brown Influenza vaccine production in liquid cell culture
US4365187A (en) * 1980-05-15 1982-12-21 Rotron Incorporated Brushless D.C. motor
US4537769A (en) * 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US7678087B2 (en) * 1999-09-29 2010-03-16 Heska Corporation Equine intranasal delivery system
US6398774B1 (en) 1999-09-29 2002-06-04 Heska Corporation Intranasal delivery system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029763A (en) * 1974-08-05 1977-06-14 Mount Sinai School Of Medicine Of The City University Of New York Influenza vaccine containing purified neuraminidase antigen and method of using the same

Also Published As

Publication number Publication date
NL7502623A (nl) 1975-09-09
GB1469901A (en) 1977-04-06
DK141172C (de) 1980-07-14
CA1052306A (fr) 1979-04-10
US4136168A (en) 1979-01-23
ZA751357B (en) 1976-02-25
FR2262962B1 (de) 1977-11-04
CH595106A5 (de) 1978-01-31
DK85775A (de) 1975-11-03
FR2262962A1 (de) 1975-10-03
ES435323A1 (es) 1976-12-16
BE826275A (fr) 1975-09-04
AU7878175A (en) 1976-09-09
JPS50160487A (de) 1975-12-25
DE2508396A1 (de) 1975-10-23

Similar Documents

Publication Publication Date Title
KR101190932B1 (ko) 인플루엔자 백신 조성물의 제조 방법
RU2496519C2 (ru) Способ получения препарата, содержащего вирусные антигены, и применение препарата
Brecher et al. Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change
Opitz et al. Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses
Kendal A comparison of “influenza C” with prototype myxoviruses: Receptor-destroying activity (neuraminidase) and structural polypeptides
EP3395826B1 (de) Verfahren zur herstellung und verwendung von influenza virus hämagglutinin komplexen
US8173021B2 (en) Method for the preparation of sulfated cellulose membranes and sulfated cellulose membranes
Buffin et al. Influenza A and B virus-like particles produced in mammalian cells are highly immunogenic and induce functional antibodies
Weigel et al. A membrane-based purification process for cell culture-derived influenza A virus
AU2005223371A1 (en) Novel assay for the separation and quantification of hemagglutinin antigens
DK141172B (da) Fremgangsmåde til fremstilling af virusproteiner af influenzavirus.
Michalski et al. The cleavage activation and sites of glycosylation in the fusion protein of Hendra virus
Bissinger et al. Towards integrated production of an influenza A vaccine candidate with MDCK suspension cells
US20220267738A1 (en) Method For Purifying An Enveloped Virus
JPH11509081A (ja) 新規の複製プロセス
Hamilton et al. Acquisition of a novel eleven amino acid insertion directly N-terminal to a tetrabasic cleavage site confers intracellular cleavage of an H7N7 influenza virus hemagglutinin
Li et al. Protein organization in Newcastle disease virus as revealed by perturbant treatment
US4195076A (en) Process for the preparation of hemagglutinin from viral sources and methods of utilizing same
Breuning et al. A reassortant between influenza A viruses (H7N2) synthesizing an enzymatically inactive neuraminidase at 40° which is not incorporated into infectious particles
Shirvan et al. Preparation of neuraminidase-specific antiserum from the H9N2 subtype of avian influenza virus
Liu et al. Construction and comparison of different source neuraminidase candidate vaccine strains for human infection with Eurasian avian-like influenza H1N1 virus
Barroso et al. Inactivation of avian influenza viruses by hydrostatic pressure as a potential vaccine development approach
Geno et al. Rapid and efficient purification of ficolin-2 using a disposable CELLine bioreactor
KR102546626B1 (ko) 인플루엔자 바이러스 항원 정제 조건 신속 확인 시험
Scheid Activation of parainfluenza viruses through host-dependent cleavage of an envelope glycoprotein